William M. Regan

William M. Regan

Katten Muchin Rosenman LLP

Contact  |  View Bio  |  RSS

Latest Posts › Clinical Trials

Share:

Life Sciences Company Obtains Dismissal of Shareholder Class Action

The US District Court for the Middle District of Tennessee recently granted BioMimetic Therapeutics Inc.’s motion to dismiss the class action against it, and denied plaintiffs leave to amend their complaint. Shareholders...more

1/23/2013 - BioMimetic Therapeutics Class Action Clinical Trials Deficiency Notices Duty to Disclose Life Sciences Securities Exchange Act Shareholder Litigation Shareholders

1 Results
|
View per page
Page: of 1